Their rather modest activity shows that such compounds may find a accepted put in place the therapeutic arsenal, although just in conjunction with materials blocking
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor
mTORC1 inhibitor
Their rather modest activity shows that such compounds may find a accepted put in place the therapeutic arsenal, although just in conjunction with materials blocking